Medtronic criticised over reaction time to pump recall
This article was originally published in Clinica
Executive Summary
Medtronic has come under fire again from the US FDA after the agency claimed that the firm failed to react to a recall of its Synchromed II programmable drug pump and its MiniMed insulin pump “in a timely manner”.